Cargando…
No Adverse Programming by Post‐Weaning Dietary Fructose of Body Weight, Adiposity, Glucose Tolerance, or Metabolic Flexibility
SCOPE: Metabolic programming can occur not only in the perinatal period, but also post‐weaning. This study aims to assess whether fructose, in comparison to glucose, in the post‐weaning diet programs body weight, adiposity, glucose tolerance, metabolic flexibility, and health at adult age. METHODS A...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814917/ https://www.ncbi.nlm.nih.gov/pubmed/29034600 http://dx.doi.org/10.1002/mnfr.201700315 |
_version_ | 1783300428729942016 |
---|---|
author | Bouwman, Lianne M. S. Fernández‐Calleja, José M. S. Swarts, Hans J. M. van der Stelt, Inge Oosting, Annemarie Keijer, Jaap van Schothorst, Evert M. |
author_facet | Bouwman, Lianne M. S. Fernández‐Calleja, José M. S. Swarts, Hans J. M. van der Stelt, Inge Oosting, Annemarie Keijer, Jaap van Schothorst, Evert M. |
author_sort | Bouwman, Lianne M. S. |
collection | PubMed |
description | SCOPE: Metabolic programming can occur not only in the perinatal period, but also post‐weaning. This study aims to assess whether fructose, in comparison to glucose, in the post‐weaning diet programs body weight, adiposity, glucose tolerance, metabolic flexibility, and health at adult age. METHODS AND RESULTS: Three‐week‐old male and female C57BL6/JRccHsd mice are given an intervention diet with 32 energy percent (en%) glucose or fructose for only 3 weeks. Next, all animals are switched to the same 40 en% high fat diet for 9 weeks. Neither body weight nor adiposity differs significantly between the animals fed with glucose or fructose diets at any point during the study in both sexes. Glucose tolerance in adulthood is not affected by the post‐weaning diet, nor are activity, energy expenditure, and metabolic flexibility, as measured by indirect calorimetry. At the end of the study, only in females fasting serum insulin levels and HOMA‐IR index are lower in post‐weaning fructose versus glucose diet (p = 0.02), without differences in pancreatic β‐cell mass. CONCLUSIONS: Our present findings indicate no adverse programming of body weight, adiposity, glucose tolerance, and metabolic flexibility by dietary (solid) fructose in comparison to glucose in the post‐weaning diet in mice. |
format | Online Article Text |
id | pubmed-5814917 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-58149172018-02-27 No Adverse Programming by Post‐Weaning Dietary Fructose of Body Weight, Adiposity, Glucose Tolerance, or Metabolic Flexibility Bouwman, Lianne M. S. Fernández‐Calleja, José M. S. Swarts, Hans J. M. van der Stelt, Inge Oosting, Annemarie Keijer, Jaap van Schothorst, Evert M. Mol Nutr Food Res Research Articles SCOPE: Metabolic programming can occur not only in the perinatal period, but also post‐weaning. This study aims to assess whether fructose, in comparison to glucose, in the post‐weaning diet programs body weight, adiposity, glucose tolerance, metabolic flexibility, and health at adult age. METHODS AND RESULTS: Three‐week‐old male and female C57BL6/JRccHsd mice are given an intervention diet with 32 energy percent (en%) glucose or fructose for only 3 weeks. Next, all animals are switched to the same 40 en% high fat diet for 9 weeks. Neither body weight nor adiposity differs significantly between the animals fed with glucose or fructose diets at any point during the study in both sexes. Glucose tolerance in adulthood is not affected by the post‐weaning diet, nor are activity, energy expenditure, and metabolic flexibility, as measured by indirect calorimetry. At the end of the study, only in females fasting serum insulin levels and HOMA‐IR index are lower in post‐weaning fructose versus glucose diet (p = 0.02), without differences in pancreatic β‐cell mass. CONCLUSIONS: Our present findings indicate no adverse programming of body weight, adiposity, glucose tolerance, and metabolic flexibility by dietary (solid) fructose in comparison to glucose in the post‐weaning diet in mice. John Wiley and Sons Inc. 2017-12-11 2018-01 /pmc/articles/PMC5814917/ /pubmed/29034600 http://dx.doi.org/10.1002/mnfr.201700315 Text en © 2017 The Authors. Published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Research Articles Bouwman, Lianne M. S. Fernández‐Calleja, José M. S. Swarts, Hans J. M. van der Stelt, Inge Oosting, Annemarie Keijer, Jaap van Schothorst, Evert M. No Adverse Programming by Post‐Weaning Dietary Fructose of Body Weight, Adiposity, Glucose Tolerance, or Metabolic Flexibility |
title | No Adverse Programming by Post‐Weaning Dietary Fructose of Body Weight, Adiposity, Glucose Tolerance, or Metabolic Flexibility |
title_full | No Adverse Programming by Post‐Weaning Dietary Fructose of Body Weight, Adiposity, Glucose Tolerance, or Metabolic Flexibility |
title_fullStr | No Adverse Programming by Post‐Weaning Dietary Fructose of Body Weight, Adiposity, Glucose Tolerance, or Metabolic Flexibility |
title_full_unstemmed | No Adverse Programming by Post‐Weaning Dietary Fructose of Body Weight, Adiposity, Glucose Tolerance, or Metabolic Flexibility |
title_short | No Adverse Programming by Post‐Weaning Dietary Fructose of Body Weight, Adiposity, Glucose Tolerance, or Metabolic Flexibility |
title_sort | no adverse programming by post‐weaning dietary fructose of body weight, adiposity, glucose tolerance, or metabolic flexibility |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814917/ https://www.ncbi.nlm.nih.gov/pubmed/29034600 http://dx.doi.org/10.1002/mnfr.201700315 |
work_keys_str_mv | AT bouwmanliannems noadverseprogrammingbypostweaningdietaryfructoseofbodyweightadiposityglucosetoleranceormetabolicflexibility AT fernandezcallejajosems noadverseprogrammingbypostweaningdietaryfructoseofbodyweightadiposityglucosetoleranceormetabolicflexibility AT swartshansjm noadverseprogrammingbypostweaningdietaryfructoseofbodyweightadiposityglucosetoleranceormetabolicflexibility AT vandersteltinge noadverseprogrammingbypostweaningdietaryfructoseofbodyweightadiposityglucosetoleranceormetabolicflexibility AT oostingannemarie noadverseprogrammingbypostweaningdietaryfructoseofbodyweightadiposityglucosetoleranceormetabolicflexibility AT keijerjaap noadverseprogrammingbypostweaningdietaryfructoseofbodyweightadiposityglucosetoleranceormetabolicflexibility AT vanschothorstevertm noadverseprogrammingbypostweaningdietaryfructoseofbodyweightadiposityglucosetoleranceormetabolicflexibility |